Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) is a publicly traded Healthcare sector company. As of October 21, 2026, RDY trades at $13.22 with a market cap of $10.90B and a P/E ratio of 0.00. RDY moved -0.29% today. Year to date, RDY is -4.33%; over the trailing twelve months it is -10.10%. Its 52-week range spans $11.36 to $16.17. Analyst consensus is buy with an average price target of $14.80. Rallies surfaces RDY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RDY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RDY recently traded at $13.22. Market cap is $10.90B. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $13.22 |
| Market Cap | $10.90B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.11% |
| 52-Week High | $16.17 |
| 52-Week Low | $11.36 |
| Volume | 26.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover RDY: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.80.